Literature DB >> 28366799

Depression of home cage wheel running is an objective measure of spontaneous morphine withdrawal in rats with and without persistent pain.

Ram Kandasamy1, Andrea T Lee2, Michael M Morgan3.   

Abstract

Opioid withdrawal in humans is often subtle and almost always spontaneous. In contrast, most preclinical studies precipitate withdrawal by administration of an opioid receptor antagonist such as naloxone. These animal studies rely on measurement of physiological symptoms (e.g., wet dog shakes) in the period immediately following naloxone administration. To more closely model the human condition, we tested the hypothesis that depression of home cage wheel running will provide an objective method to measure the magnitude and duration of spontaneous morphine withdrawal. Rats were allowed access to a running wheel in their home cage for 8days prior to implantation of two 75mg morphine or placebo pellets. The pellets were removed 3 or 5days later to induce spontaneous withdrawal. In normal pain-free rats, removal of the morphine pellets depressed wheel running for 48h compared to rats that had placebo pellets removed. Morphine withdrawal-induced depression of wheel running was greatly enhanced in rats with persistent inflammatory pain induced by injection of Complete Freund's Adjuvant (CFA) into the hindpaw. Removal of the morphine pellets following 3days of treatment depressed wheel running in these rats for over 6days. These data demonstrate that home cage wheel running provides an objective and more clinically relevant method to assess spontaneous morphine withdrawal compared to precipitated withdrawal in laboratory rats. Moreover, the enhanced withdrawal in rats with persistent inflammatory pain suggests that pain patients may be especially susceptible to opioid withdrawal.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Addiction; Dependence; Locomotor activity; Opioid withdrawal; Tolerance

Mesh:

Substances:

Year:  2017        PMID: 28366799      PMCID: PMC5484634          DOI: 10.1016/j.pbb.2017.03.007

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  32 in total

1.  Intracranial self-stimulation reward thresholds during morphine withdrawal in rats bred for high (HiS) and low (LoS) saccharin intake.

Authors:  Nathan A Holtz; Anna K Radke; Natalie E Zlebnik; Andrew C Harris; Marilyn E Carroll
Journal:  Brain Res       Date:  2015-01-09       Impact factor: 3.252

Review 2.  Opioid Abuse in Chronic Pain--Misconceptions and Mitigation Strategies.

Authors:  Nora D Volkow; A Thomas McLellan
Journal:  N Engl J Med       Date:  2016-03-31       Impact factor: 91.245

Review 3.  Drug abuse, dependence, and addiction in chronic pain patients.

Authors:  D A Fishbain; H L Rosomoff; R S Rosomoff
Journal:  Clin J Pain       Date:  1992-06       Impact factor: 3.442

4.  Home cage wheel running is an objective and clinically relevant method to assess inflammatory pain in male and female rats.

Authors:  Ram Kandasamy; Jonas J Calsbeek; Michael M Morgan
Journal:  J Neurosci Methods       Date:  2016-02-15       Impact factor: 2.390

5.  Opioid-induced hyperalgesia and incisional pain.

Authors:  X Li; M S Angst; J D Clark
Journal:  Anesth Analg       Date:  2001-07       Impact factor: 5.108

6.  Persistent pain maintains morphine-seeking behavior after morphine withdrawal through reduced MeCP2 repression of GluA1 in rat central amygdala.

Authors:  Yuan-Yuan Hou; You-Qing Cai; Zhizhong Z Pan
Journal:  J Neurosci       Date:  2015-02-25       Impact factor: 6.167

7.  Pharmacokinetics and pharmacodynamics of subcutaneous morphine pellets in the rat.

Authors:  B C Yoburn; J Chen; T Huang; C E Inturrisi
Journal:  J Pharmacol Exp Ther       Date:  1985-11       Impact factor: 4.030

Review 8.  Opioid dependence and addiction during opioid treatment of chronic pain.

Authors:  Jane C Ballantyne; Steven K LaForge
Journal:  Pain       Date:  2007-05-04       Impact factor: 6.961

Review 9.  The Clinical Opiate Withdrawal Scale (COWS).

Authors:  Donald R Wesson; Walter Ling
Journal:  J Psychoactive Drugs       Date:  2003 Apr-Jun

10.  Anxiogenic-like effects of spontaneous and naloxone-precipitated opiate withdrawal in the elevated plus-maze.

Authors:  G Schulteis; M Yackey; V Risbrough; G F Koob
Journal:  Pharmacol Biochem Behav       Date:  1998-07       Impact factor: 3.533

View more
  7 in total

Review 1.  Pros and Cons of Clinically Relevant Methods to Assess Pain in Rodents.

Authors:  Anke Tappe-Theodor; Tamara King; Michael M Morgan
Journal:  Neurosci Biobehav Rev       Date:  2019-03-15       Impact factor: 8.989

2.  Medication overuse headache following repeated morphine, but not [INCREMENT]9-tetrahydrocannabinol administration in the female rat.

Authors:  Ram Kandasamy; Cole T Dawson; Tammy N Hilgendorf; Michael M Morgan
Journal:  Behav Pharmacol       Date:  2018-08       Impact factor: 2.293

3.  Anti-migraine effect of ∆9-tetrahydrocannabinol in the female rat.

Authors:  Ram Kandasamy; Cole T Dawson; Rebecca M Craft; Michael M Morgan
Journal:  Eur J Pharmacol       Date:  2017-10-28       Impact factor: 4.432

4.  Use of home cage wheel running to assess the behavioural effects of administering a mu/delta opioid receptor heterodimer antagonist for spontaneous morphine withdrawal in the rat.

Authors:  Michael M Morgan; Danielle L Peecher; John M Streicher
Journal:  Behav Brain Res       Date:  2020-10-06       Impact factor: 3.332

5.  Comparative benefits of social housing and buprenorphine on wheel running depressed by morphine withdrawal in rats.

Authors:  Jonah D Stickney; Michael M Morgan
Journal:  Psychopharmacology (Berl)       Date:  2021-07-10       Impact factor: 4.530

6.  Morphine restores and naloxone-precipitated withdrawal depresses wheel running in rats with hindpaw inflammation.

Authors:  Michael M Morgan; Kristin Ataras
Journal:  Pharmacol Biochem Behav       Date:  2021-08-04       Impact factor: 3.697

Review 7.  'Reinventing the wheel' to advance the development of pain therapeutics.

Authors:  Ram Kandasamy; Michael M Morgan
Journal:  Behav Pharmacol       Date:  2021-04-01       Impact factor: 2.277

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.